Literature DB >> 31589979

Impedance and Histologic Characteristics of the Sub-Laryngeal Esophagus Distinguish Eosinophilic Esophagitis From Other Esophageal Disorders.

Yash A Choksi1, Jasmine Chaparro1, Michael Blanco1, Rohit Sharda1, Shabnam Sarker1, Sarah Ferguson1, Tina Higginbotham1, Girish Hiremath2, Frank Revetta3, M Kay Washington3, Christopher S Williams1, Michael F Vaezi4.   

Abstract

BACKGROUND & AIMS: The region of the esophagus 15-17 cm below the incisors, called the sub-upper esophageal sphincter (sub-UES), has not been characterized in adults with eosinophilic esophagitis (EoE) but appears different during endoscopy. We investigated how the sub-UES differs from the remaining esophagus in patients with EoE and aimed to determine whether these differences be used to distinguish patients with EoE from those with lichen planus.
METHODS: We performed a prospective study of 14 patients with EoE, 7 patients with lichen planus (based on presence of Civatte bodies, dysphagia, and/or narrow esophagus with thin esophageal mucosa without signs of EoE), and 20 patients undergoing upper endoscopy for upper gastrointestinal or with dysphagia but without features of EoE (controls) at a single medical center from 2015 through 2018. Biopsies from the distal, middle, and sub-UES regions of the esophagus were analyzed by histology, quantitative PCR, and immunohistochemistry. We measured mucosal impedance (MI) in all subjects at the sub-UES and 2 cm, 5 cm, and 10 cm from the gastro-esophageal junction.
RESULTS: Patients with EoE had significantly fewer eosinophils (median, 2 eosinophils/high-powered field [HPF]; range, 0-8 eosinophils/HPF) in sub-UES tissues compared with distal esophagus (median, 50 eosinophils/HPF; range, 22.5-60.8 eosinophils/HPF; P < .0001) or middle esophagus (median, 32 eosinophils/HPF; range, 19.3-60; P < .0001). Sub-UES tissues from patients with EoE had significantly less basal cell hyperplasia (P < .01), papillary elongation (P < .01), and dilated intercellular spaces (P < .01) than middle or and distal esophagus. MI in the sub-UES did not differ significantly between patients with EoE vs controls (P = .24), but was significantly lower in patients with lichen planus (median, 1344 ohms; range, 1046-1488) than patients with EoE (median, 2880 ohms; range, 2149-4858) (P < .001). mRNA and protein expression patterns did not differ significantly in the sub-UES of patients with EoE vs controls, except for expression of desmoglein-1, which was increased in sub-UES tissues from patients with EoE.
CONCLUSIONS: Sub-UES tissues from patients with EoE differ in numbers of eosinophils, histologic features, and MI compared to controls or patients with lichen planus. These features might help to distinguish these 2 diseases.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DSG1 Expression; Diagnosis; Inflammation; Mucosal Impedance

Year:  2019        PMID: 31589979      PMCID: PMC8019324          DOI: 10.1016/j.cgh.2019.09.032

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  28 in total

1.  Use of direct, endoscopic-guided measurements of mucosal impedance in diagnosis of gastroesophageal reflux disease.

Authors:  Elif Saritas Yuksel; Tina Higginbotham; James C Slaughter; Jerry Mabary; Robert T Kavitt; C Gaelyn Garrett; Michael F Vaezi
Journal:  Clin Gastroenterol Hepatol       Date:  2012-05-27       Impact factor: 11.382

2.  Development and Validation of a Mucosal Impedance Contour Analysis System to Distinguish Esophageal Disorders.

Authors:  Dhyanesh A Patel; Tina Higginbotham; James C Slaughter; Muhammad Aslam; Elif Yuksel; David Katzka; C Prakash Gyawali; Melina Mashi; John Pandolfino; Michael F Vaezi
Journal:  Gastroenterology       Date:  2019-01-31       Impact factor: 22.682

3.  The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark.

Authors:  E S Dellon; R Erichsen; J A Baron; N J Shaheen; M Vyberg; H T Sorensen; L Pedersen
Journal:  Aliment Pharmacol Ther       Date:  2015-02-12       Impact factor: 8.171

4.  Eosinophilic esophagitis-linked calpain 14 is an IL-13-induced protease that mediates esophageal epithelial barrier impairment.

Authors:  Benjamin P Davis; Emily M Stucke; M Eyad Khorki; Vladislav A Litosh; Jeffrey K Rymer; Mark Rochman; Jared Travers; Leah C Kottyan; Marc E Rothenberg
Journal:  JCI Insight       Date:  2016-04

5.  Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis.

Authors:  Carine Blanchard; Ning Wang; Keith F Stringer; Anil Mishra; Patricia C Fulkerson; J Pablo Abonia; Sean C Jameson; Cassie Kirby; Michael R Konikoff; Margaret H Collins; Mitchell B Cohen; Rachel Akers; Simon P Hogan; Amal H Assa'ad; Philip E Putnam; Bruce J Aronow; Marc E Rothenberg
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

6.  Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium.

Authors:  Takuya Suzuki; Naho Yoshinaga; Soichi Tanabe
Journal:  J Biol Chem       Date:  2011-07-19       Impact factor: 5.157

7.  BMP-driven NRF2 activation in esophageal basal cell differentiation and eosinophilic esophagitis.

Authors:  Ming Jiang; Wei-Yao Ku; Zhongren Zhou; Evan S Dellon; Gary W Falk; Hiroshi Nakagawa; Mei-Lun Wang; Kuancan Liu; Jun Wang; David A Katzka; Jeffrey H Peters; Xiaopeng Lan; Jianwen Que
Journal:  J Clin Invest       Date:  2015-03-16       Impact factor: 14.808

8.  Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease.

Authors:  Evan S Dellon; Wood B Gibbs; Karen J Fritchie; Tara C Rubinas; Lindsay A Wilson; John T Woosley; Nicholas J Shaheen
Journal:  Clin Gastroenterol Hepatol       Date:  2009-09-03       Impact factor: 11.382

9.  GWAS identifies four novel eosinophilic esophagitis loci.

Authors:  Patrick M A Sleiman; Mei-Lun Wang; Antonella Cianferoni; Seema Aceves; Nirmala Gonsalves; Kari Nadeau; Albert J Bredenoord; Glenn T Furuta; Jonathan M Spergel; Hakon Hakonarson
Journal:  Nat Commun       Date:  2014-11-19       Impact factor: 14.919

10.  The Salivary Microbiome Is Altered in Children With Eosinophilic Esophagitis and Correlates With Disease Activity.

Authors:  Girish Hiremath; Meghan H Shilts; Helen H Boone; Hernan Correa; Sari Acra; Andrey Tovchigrechko; Seesandra V Rajagopala; Suman R Das
Journal:  Clin Transl Gastroenterol       Date:  2019-06       Impact factor: 4.488

View more
  4 in total

Review 1.  Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction.

Authors:  Pengxu Wei
Journal:  Toxins (Basel)       Date:  2022-04-30       Impact factor: 5.075

Review 2.  EoE disease monitoring: Where we are and where we are going.

Authors:  Bridget Godwin; Benjamin Wilkins; Amanda B Muir
Journal:  Ann Allergy Asthma Immunol       Date:  2019-12-09       Impact factor: 6.347

Review 3.  Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Authors:  Seema Aceves; Margaret H Collins; Marc E Rothenberg; Glenn T Furuta; Nirmala Gonsalves
Journal:  J Allergy Clin Immunol       Date:  2019-11-20       Impact factor: 10.793

4.  Mucosal Integrity Testing Can Detect Differences in the Rectums of Patients with Inflammatory Bowel Disease Compared to Controls: A Pilot Study.

Authors:  Miles Basil; David Schwartz; Robin Dalal; Sara Horst; Elizabeth Scoville; Dawn Adams; Dawn Beaulieu; James C Slaughter; Tina Higginbotham; Michael Vaezi; Yash Choksi
Journal:  Dig Dis Sci       Date:  2021-02-27       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.